Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review

• Ngā kaituhi matua: Qiang Tong (Author), Peng-chong Zhu (Author), Zhuang Zhuang (Author), Li-hui Deng (Author), Zi-hao Wang (Author), Hua Zeng (Author), Guo-qing Zheng (Author), Yan Wang (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2019-10-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Notoginsenoside R1 (NGR1) exerts pharmacological actions for a variety of diseases such as myocardial infarction, ischemic stroke, acute renal injury, and intestinal injury. Here, we conducted a preclinical systematic review of NGR1 for ischemia reperfusion (I/R) injury. Eight databases were searche...